Dermatologicals in New Zealand
Over the review period, many mainstream supermarket brands saw the opportunity to develop products suitable for those with sensitive, dry and problematic skin. This was to the detriment of dermatological brands, which are mainly available through chemists/pharmacies, and have a higher content of active pharmaceutical ingredients. The trend for more natural content or less harmful ingredients has made these mainstream brands more acceptable to the public, as the branding is already well-known and...
Euromonitor International's Dermatologicals in New Zealand report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2012-2016, allowing you to identify the sectors driving growth. Forecasts to 2021 illustrate how the market is set to change.
Product coverage: Antiparasitics/Lice (Head and Body) Treatments, Antipruritics, Cold Sore Treatments, Haemorrhoid Treatments, Hair Loss Treatments, Medicated Shampoos, Nappy (Diaper) Rash Treatments, Paediatric Dermatologicals, Topical Allergy Remedies/Antihistamines, Topical Antifungals, Topical Germicidals/Antiseptics, Vaginal Antifungals.
Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.
Why buy this report?
- Get a detailed picture of the Dermatologicals market;
- Pinpoint growth sectors and identify factors driving change;
- Understand the competitive environment, the market’s major players and leading brands;
- Use five-year forecasts to assess how the market is predicted to develop.
Euromonitor International has over 40 years' experience of publishing market research reports, business reference books and online information systems. With offices in London, Chicago, Singapore, Shanghai, Vilnius, Dubai, Cape Town, Santiago, Sydney, Tokyo and Bangalore and a network of over 800 analysts worldwide, Euromonitor International has a unique capability to develop reliable information resources to help drive informed strategic planning.
- DERMATOLOGICALS IN NEW ZEALAND
- Euromonitor International
- November 2017
- LIST OF CONTENTS AND TABLES
- Mainstream Brands Threaten Dermatologicals
- Allergies and Eczema Closely Related
- Competitive Landscape
- Johnson & Johnson Pacific (nz) Continues To Lead
- Niche Opportunities for Distributed Products
- Forecast Period Trends
- Category Data
- Table 1 Sales of Dermatologicals by Category: Value 2012-2017
- Table 2 Sales of Dermatologicals by Category: % Value Growth 2012-2017
- Table 3 NBO Company Shares of Dermatologicals: % Value 2013-2017
- Table 4 LBN Brand Shares of Dermatologicals: % Value 2014-2017
- Table 5 LBN Brand Shares of Hair Loss Treatments: % Value 2014-2017
- Table 6 Forecast Sales of Dermatologicals by Category: Value 2017-2022
- Table 7 Forecast Sales of Dermatologicals by Category: % Value Growth 2017-2022
- Executive Summary
- Consistent Growth Overall
- Age Segmentation Continues
- Hybrid Product Developments
- Internet Sales Expected To Increase
- Modest Growth Expected Over the Forecast Period
- Market Indicators
- Table 8 Consumer Expenditure on Health Goods and Medical Services: Value 2012-2017
- Table 9 Life Expectancy at Birth 2012-2017
- Market Data
- Table 10 Sales of Consumer Health by Category: Value 2012-2017
- Table 11 Sales of Consumer Health by Category: % Value Growth 2012-2017
- Table 12 NBO Company Shares of Consumer Health: % Value 2013-2017
- Table 13 LBN Brand Shares of Consumer Health: % Value 2014-2017
- Table 14 Penetration of Private Label in Consumer Health by Category: % Value 2012-2017
- Table 15 Distribution of Consumer Health by Format: % Value 2012-2017
- Table 16 Distribution of Consumer Health by Format and Category: % Value 2017
- Table 17 Forecast Sales of Consumer Health by Category: Value 2017-2022
- Table 18 Forecast Sales of Consumer Health by Category: % Value Growth 2017-2022
- OTC Registration and Classification
- Vitamins and Dietary Supplements Registration and Classification
- Self-medication/self-care and Preventive Medicine
- Summary 1 OTC: Switches 2016-2017
- Summary 2 Research Sources